NORML
OCTOBER 21, 2019
The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.
The Cannigma
MAY 19, 2021
However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. But in modern times?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Freedom Leaf
JULY 20, 2017
They reported that subjects’ cannabis use history was correlated with a “small, yet consistent increase in odds” for hypertension, obesity and other risk factors. Specifically, a 2016 study involving a significantly larger cohort of NHANES participants reported that “current marijuana use is associated with lower odds of metabolic syndrome.”
Cannabis Law Report
JANUARY 24, 2022
History of Medical Use of Cannabis in North America. History of Industrial Use of Cannabis in North America. North America Legal Cannabis Number of clinical trials. Hemp Market Estimates and Forecasts, 2016-2028 (USD Million). Marijuana Market Estimates and Forecasts, 2016-2028 (USD Million). Supplements.
Cannabis Law Report
JULY 9, 2021
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].
CannaMD
AUGUST 26, 2020
Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., CBD also reduced experimental anxiety and prevented the development of high impulsivity in rats with an alcohol dependence history. mice/rats). Hepatic protection.
Cannabis Law Report
DECEMBER 14, 2019
Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Writes Investing News.com.
Expert insights. Personalized for you.
104 
Let's personalize your content